Share Us: Subscribe | Contact

Biblio

Export 1335 results:

Tagged

Filters: First Letter Of Last Name is G [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

T

D. Gouilly, Tisserand, C., Nogueira, L., Saint-Lary, L., Rousseau, V., Benaiteau, M., Rafiq, M., Carlier, J., Milongo-Rigal, E., Pagès, J. - C., and Pariente, J., “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.

S

L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.

Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., “A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.”, J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.

E. C. Edmonds, Delano-Wood, L., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.

C. Ramos, Villalba, C., García, J., Lanata, S., López, H., Aguillón, D., Cordano, C., Madrigal, L., Aguirre-Acevedo, D. C., and Lopera, F., “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.

Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.

Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.

Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.

J. I. Ali, Smart, C. M., and Gawryluk, J. R., “Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 1, pp. 303-320, 2018.

N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.

A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.

A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.

A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.

C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.

C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.

Y. - T. Dong, Cao, K., Tan, L. - C., Wang, X. - L., Qi, X. - L., Xiao, Y., and Guan, Z. - Z., “Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide.”, J Alzheimers Dis, vol. 63, no. 1, pp. 283-301, 2018.

V. K. Ramanan, Przybelski, S. A., Graff-Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., Petersen, R. C., and Vemuri, P., “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.

A. Chincarini, Sensi, F., Rei, L., Bossert, I., Morbelli, S., Guerra, U. Paolo, Frisoni, G., Padovani, A., and Nobili, F., “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.

H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., “Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.”, J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.

E. Grober, Qi, Q., Kuo, L., Hassenstab, J., Perrin, R. J., and Lipton, R. B., “Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 185-195, 2021.

W. Watremez, Jackson, J., Almari, B., McLean, S. L., Grayson, B., Neill, J. C., Fischer, N., Allouche, A., Koziel, V., Pillot, T., and Harte, M. K., “Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.”, J Alzheimers Dis, vol. 62, no. 1, pp. 213-226, 2018.

J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.

E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.

E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.

A. Tiiman, Luo, J., Wallin, C., Olsson, L., Lindgren, J., Jarvet, J., Per, R., Sholts, S. B., Rahimipour, S., Abrahams, J. Pieter, Karlström, A. Eriksson, Gräslund, A., and Wärmländer, S. K. T. S., “Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.”, J Alzheimers Dis, vol. 54, no. 3, pp. 971-982, 2016.

Pages